Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pradeep Poonnen"'
Autor:
Anna Hung, Kyung Min Lee, Julie A. Lynch, Yanhong Li, Pradeep Poonnen, Olga V. Efimova, Bradley J. Hintze, Trudy Buckingham, Candice Yong, Brian Seal, Michael J. Kelley, Shelby D. Reed
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background The Veterans Health Administration (VHA) is the largest integrated health care system in the United States (US). Among VHA patients, the rate of use of concurrent chemoradiation therapy (CCRT) among those with unresectable, stage
Externí odkaz:
https://doaj.org/article/750fdfa47ed44f2a96ca37f437898721
Autor:
Hanna K Sanoff, Lindsay A Renfro, Pradeep Poonnen, Pratibha Ambadwar, Daniel J Sargent, Richard M Goldberg, Howard McLeod
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94727 (2014)
Colorectal cancer (CRC) risk is partly conferred by common, low-penetrance single nucleotide polymorphisms (SNPs). We hypothesized that these SNPs are associated with outcomes in metastatic CRC.Six candidate SNPs from 8q24, 10p14, 15q13, 18q21 were i
Externí odkaz:
https://doaj.org/article/edd25e9487834610ba60cc4912fd4d3e
Autor:
Tianjiao Wang, Juan Gomez-Gelvez, Pradeep Poonnen, Noah A. Brown, Alexandra C. Hristov, Nathanael G. Bailey, Sumana Devata, Ryan A. Wilcox, Tycel Phillips, Carlos Murga-Zamalloa, Kedar V. Inamdar, Walter Hanel, Pinki Chowdhury, Avery Polk
Publikováno v:
Oncotarget
Survival following anthracycline-based chemotherapy remains poor among patients with most T-cell lymphoproliferative disorders. This may be attributed, at least in part, to cell-autonomous mechanisms of chemotherapy resistance observed in these lymph
Autor:
Daniel J. Sargent, Hanna K. Sanoff, Pradeep Poonnen, Lindsay A. Renfro, Richard M. Goldberg, Pratibha B. Ambadwar, Howard L. McLeod
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94727 (2014)
PLoS ONE
PLoS ONE
Background Colorectal cancer (CRC) risk is partly conferred by common, low-penetrance single nucleotide polymorphisms (SNPs). We hypothesized that these SNPs are associated with outcomes in metastatic CRC. Methods Six candidate SNPs from 8q24, 10p14,